Regulatory tracker: Sanofi, Regeneron's Dupixent approved for adolescents with sinusitis
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Wednesday, September 18 …